Cancel
Known information
- Served as a member of the Board since June 2020
- Served as interim Chief Executive Officer from January 2022 to May 2022
- Was a Partner with B2B CFO Partners, LLC from April 2020 to January 2022
- Served as the President and Chief Executive Officer of K.P. Diamond Eagle, Inc. from November 2019 to March 2020
- Worked as a Senior Director within Alvarez & Marsal's Private Equity Performance Improvement Practice, LLP from August 2018 to October 2019
- Served as President and Chief Executive Officer of K.P. Diamond Eagle, Inc. from October 206 to July 2018
- Was the Chief Financial Officer of Fuel Systems Solutions, Inc. from April 2011 to October 2016
- Is a Certified Public Accountant
- Also a Certified Public Auditor and a Chartered Certified Accountant in Italy
- Developed significant knowledge of US GAAP and IFRS
- Earned a BA and MA in Business Economics from L. Bocconi University, Italy
About Kiromic BioPharma
Kiromic BioPharma, based in Houston, Texas, focuses on developing innovative cell therapies for cancer using its proprietary DIAMOND AI and ABBIE platforms to enhance target identification and improve manufacturing processes.
Report inaccurate information
